Sentante Secures €6 Million in New Funding to Revolutionize Endovascular Care
Sentante announces the closing of a €6 Million seed funding round led by Practica Capital with participation of EIC fund. The company will use the
Sentante announces the closing of a €6 Million seed funding round led by Practica Capital with participation of EIC fund. The company will use the
Thrilled to announce that Ricardo Hanel has joined our Medical Advisory Board! With over two decades of experience in shaping endovascular neurosurgery, Dr. Hanel brings his knowledge
Paris Vascular Insights Symposium #PVI2023 took center stage at the same venue as Paris Fashion Week! 🌟 While the runway dazzled with style, our very own Tomas Baltrunas rocked the
Absolutely thrilled to participate in MedTech Innovator, the world’s largest accelerator of medical technology companies and the premier nonprofit startup accelerator in the medical technology industry.
🌊 Riding the Innovation Wave at #PTCHN2023! Tomas Baltrunas presented Sentante at the prestigious XIII-International-Conference of the Polish Society for Vascular Surgery in Warsaw, Poland. Huge thanks to all
Proud moment at Society of Robotic Surgery | SRS annual meeting! Tomas Baltrunas took the stage to present Sentante unveiling some of the most remarkable features that set it apart
Sentante presented at ICCA Stroke Conference, 2023 – thrilling! ICCA Stroke brought together leading minds in the field to discuss groundbreaking advancements in stroke research and treatment. 🎯All united
🌉 San Francisco – the perfect meeting point for groundbreaking ideas and transformative collaborations! We are happy to share that we’ve landed ourselves a spot
We are excited to announce that Christopher Prentice has joined our business advisory board! With over 20 years of exceptional experience in both well-established multinational companies and
Incredible opportunity to unveil the first-ever fully robotic endovascular thrombectomy procedure at the Leipzig Interventional Course #LINC23! During presentation, Tomas Baltrunas highlighted the tremendous promise of incorporating robotics
Sentante © Copyright 2023
UAB Inovatyvi Medicina
VAT LT100011754612
Vytauto pr. 23, Kaunas
44352, Lithuania
UAB Inovatyvi medicina
VAT LT100011754612
Vytauto pr. 23, Kaunas
44352, Lithuania